Cumberland Pharmaceuticals, Inc. (CPIX)
3.17
+0.07
(+2.26%)
USD |
NASDAQ |
Apr 02, 16:00
3.11
-0.06
(-1.89%)
After-Hours: 20:00
Cumberland Pharmaceuticals EPS Diluted (Quarterly) : -0.0944 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ImmuCell Corp. | -0.315 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.429M |
| Revenue (Quarterly) | 13.68M |
| Total Expenses (Quarterly) | 15.09M |
| Enterprise Value | 45.81M |
| Gross Profit Margin (Quarterly) | 76.00% |
| Profit Margin (Quarterly) | -10.44% |
| Earnings Yield | -6.01% |
| Normalized Earnings Yield | -5.827 |